A detailed history of Allred Capital Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Allred Capital Management, LLC holds 9,084 shares of EW stock, worth $594,820. This represents 0.32% of its overall portfolio holdings.

Number of Shares
9,084
Previous 7,981 13.82%
Holding current value
$594,820
Previous $762,000 10.1%
% of portfolio
0.32%
Previous 0.3%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $92,982 - $104,023
1,103 Added 13.82%
9,084 $839,000
Q1 2024

Apr 16, 2024

BUY
$72.54 - $95.56 $174,096 - $229,344
2,400 Added 43.0%
7,981 $762,000
Q3 2023

Nov 08, 2023

BUY
$69.28 - $93.38 $92,558 - $124,755
1,336 Added 31.47%
5,581 $386,000
Q2 2023

Jul 20, 2023

BUY
$81.41 - $94.33 $3,419 - $3,961
42 Added 1.0%
4,245 $400,000
Q1 2023

May 09, 2023

BUY
$74.26 - $84.51 $74 - $84
1 Added 0.02%
4,203 $347,000
Q1 2022

May 05, 2022

SELL
$101.96 - $128.34 $56,995 - $71,742
-559 Reduced 11.74%
4,202 $494,000
Q4 2021

Jan 25, 2022

BUY
$106.37 - $130.68 $22,231 - $27,312
209 Added 4.59%
4,761 $616,000
Q3 2021

Oct 12, 2021

SELL
$102.91 - $122.75 $21,199 - $25,286
-206 Reduced 4.33%
4,552 $515,000
Q2 2021

Aug 05, 2021

BUY
$83.84 - $104.76 $79,983 - $99,941
954 Added 25.08%
4,758 $492,000
Q1 2021

May 06, 2021

BUY
$78.68 - $90.67 $17,073 - $19,675
217 Added 6.05%
3,804 $318,000
Q4 2020

Jan 21, 2021

BUY
$71.69 - $91.23 $33,264 - $42,330
464 Added 14.86%
3,587 $327,000
Q3 2020

Oct 14, 2020

BUY
$67.19 - $87.44 $193,843 - $252,264
2,885 Added 1212.18%
3,123 $249,000
Q1 2020

Apr 17, 2020

SELL
$52.41 - $81.0 $733 - $1,134
-14 Reduced 5.56%
238 $44.9 Million
Q4 2019

Jan 13, 2020

BUY
$71.7 - $82.09 $18,068 - $20,686
252 New
252 $19,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Allred Capital Management, LLC Portfolio

Follow Allred Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allred Capital Management, LLC with notifications on news.